Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer
- PMID: 20514403
Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer
Abstract
Green tea catechins have been reported to have antitumor activity. The objective of this study was to examine the effect of catechins on the antitumor efficacy of doxorubicin (DOX) in a murine model for chemoresistant hepatocellular carcinoma (HCC). Epicatechin gallate (ECG) and epigallocatechin gallate (EGCG) are the most abundant polyphenolic compounds in green tea. Here, we show that ECG or EGCG at higher doses had a slight inhibitory effect on cell proliferation in the resistant human HCC cell line BEL-7404/DOX in vitro and in vivo, whereas the administration of DOX with these compounds at lower doses significantly inhibited HCC cell proliferation in vitro and hepatoma growth in a xenograft mouse model, compared with treatment with either agent alone at the same dose. Furthermore, the administration of DOX in combination with ECG or EGCG markedly enhanced intracellular DOX accumulation, which implies that the catechins inhibited P-glycoprotein (P-gp) efflux pump activity. Consistent with these results, the intracellular retention of rhodamine 123, a P-gp substrate, was increased and the level of P-gp was decreased in cells concurrently treated with DOX and ECG or EGCG. EGCG increased topo II expression, but did not alter GST protein levels in tumor xenografts. The expression of MDR1 and HIF-1alpha mRNA was obviously reduced, whereas MRP1 and LRP expression was not changed significantly. These data suggest that tea catechins at non-toxic doses can augment DOX-induced cell killing and sensitize chemoresistant HCC cells to DOX. The chemosensitizing effect of catechins may occur directly or indirectly by reversal of multidrug resistance, involving the suppression of MDR1 expression, or by enhancement of intracellular DOX accumulation, involving inhibition of P-gp function.
Similar articles
-
New cancer treatment strategy using combination of green tea catechins and anticancer drugs.Cancer Sci. 2011 Feb;102(2):317-23. doi: 10.1111/j.1349-7006.2010.01805.x. Epub 2010 Dec 30. Cancer Sci. 2011. PMID: 21199169 Review.
-
Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells.Biomed Pharmacother. 2005 Apr;59(3):64-9. doi: 10.1016/j.biopha.2005.01.002. Biomed Pharmacother. 2005. PMID: 15795098 Review.
-
Reversal of cancer multidrug resistance by green tea polyphenols.J Pharm Pharmacol. 2004 Oct;56(10):1307-14. doi: 10.1211/0022357044364. J Pharm Pharmacol. 2004. PMID: 15482646
-
Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.Cancer Chemother Pharmacol. 2005 Feb;55(2):179-88. doi: 10.1007/s00280-004-0868-0. Epub 2004 Sep 16. Cancer Chemother Pharmacol. 2005. PMID: 15378274
-
EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.Br J Cancer. 2001 Mar 23;84(6):844-50. doi: 10.1054/bjoc.2000.1691. Br J Cancer. 2001. PMID: 11259102 Free PMC article.
Cited by
-
A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways.Med Oncol. 2024 May 4;41(6):134. doi: 10.1007/s12032-024-02333-5. Med Oncol. 2024. PMID: 38703282 Review.
-
What nature has to offer: Opportunities for immuno-oncology.J Food Drug Anal. 2023 Jun 15;31(2):212-231. doi: 10.38212/2224-6614.3459. J Food Drug Anal. 2023. PMID: 37335163 Free PMC article. Review.
-
The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma.Front Pharmacol. 2023 May 24;14:1201085. doi: 10.3389/fphar.2023.1201085. eCollection 2023. Front Pharmacol. 2023. PMID: 37292151 Free PMC article. Review.
-
Anticancer Therapeutic Effects of Green Tea Catechins (GTCs) When Integrated with Antioxidant Natural Components.Molecules. 2023 Feb 24;28(5):2151. doi: 10.3390/molecules28052151. Molecules. 2023. PMID: 36903395 Free PMC article. Review.
-
Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells - A potential contribution to the predictive, preventive, and personalized medicine.J Adv Res. 2024 Jan;55:103-118. doi: 10.1016/j.jare.2023.02.015. Epub 2023 Mar 4. J Adv Res. 2024. PMID: 36871616 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous